FIELD: medicine.
SUBSTANCE: enzyme immunoassay is used to measure blood serum neopterin NP, vascular cellular adhesion molecules vCAM, intracellular cell adhesion molecules ICAM, tumour necrosis factor TNF-α, interleukin-6 IL-6. The coefficient K is calculated by formula:
EFFECT: using the given technique enables providing a higher objectivity of the differential diagnosis of the benign and malignant osseous growth by using a complex of the specified immunological markers.
2 ex
Title | Year | Author | Number |
---|---|---|---|
PREOPERATIVE DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BONE TISSUE NEOPLASMS | 2014 |
|
RU2570748C1 |
DIAGNOSTIC TECHNIQUE FOR BONE TUMOURS | 2011 |
|
RU2454665C1 |
GASTRIC CANCER IMMUNODIAGNOSIS METHOD | 2023 |
|
RU2818734C1 |
DIAGNOSTIC TECHNIQUE FOR RISK OF ANTITUMOR IMMUNE PROTECTION DEFICIENCY | 2015 |
|
RU2605310C1 |
METHOD FOR PREDICTING SEVERE JAUNDICE OF BENIGN GENESIS | 2018 |
|
RU2677468C1 |
METHOD FOR PREDICTING RISK OF MALIGNANT NEW GROWTHS | 2014 |
|
RU2552305C1 |
METHOD FOR ONCOLOGICAL DISEASES COURSE PREDICTION | 2016 |
|
RU2622756C1 |
METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
METHOD FOR DIAGNOSING BREAST CANCER AND OVARIAN CANCER BY MMP-9 MRNA LEVEL IN BLOOD PLASMA | 2020 |
|
RU2745424C1 |
METHOD FOR ASSESSING THE SENSITIVITY OF A TUMOR TO IMMUNO-ONCOLOGICAL DRUGS | 2021 |
|
RU2771760C1 |
Authors
Dates
2014-07-10—Published
2013-04-19—Filed